Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?

Hoppenot C, Peters P, Cowan M, Moore ED, Hurteau J, Lee NK, Yamada SD.

Gynecol Oncol. 2019 Jul;154(1):177-182. doi: 10.1016/j.ygyno.2019.04.681. Epub 2019 May 2.

PMID:
31056111
2.

Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.

Rodriguez GC, Kauderer J, Hunn J, Thaete LG, Watkin WG, Russell S, Yozwiak M, Basil J, Hurteau J, Lele S, Modesitt SC, Zivanovic O, Zhang HH, Bartels PH, Alberts DS.

Cancer Prev Res (Phila). 2019 Jun;12(6):401-412. doi: 10.1158/1940-6207.CAPR-18-0383. Epub 2019 Apr 23.

PMID:
31015198
3.

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.

Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA.

Ann Oncol. 2019 Apr 1;30(4):551-557. doi: 10.1093/annonc/mdz018.

PMID:
30753272
4.

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.

Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.

5.

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.

Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH.

Gynecol Oncol. 2018 Jul;150(1):79-84. doi: 10.1016/j.ygyno.2018.04.564. Epub 2018 May 4.

PMID:
29735278
6.

Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2018 Feb;23(2):272. doi: 10.1634/theoncologist.2014-0009erratum. No abstract available.

7.

Ovarian Yolk Sac Tumors; Does Age Matter?

Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F, Krailo M, Billmire D, Patte C, Fresneau B, Shaikh F, Stoneham S, Nicholson J, Murray M, Frazier AL.

Int J Gynecol Cancer. 2018 Jan;28(1):77-84. doi: 10.1097/IGC.0000000000001149. Erratum in: Int J Gynecol Cancer. 2018 May;28(4):851.

PMID:
29194189
8.

Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.

Bishop EA, Java JJ, Moore KN, Spirtos NM, Pearl ML, Zivanovic O, Kushner DM, Backes F, Hamilton CA, Geller MA, Hurteau J, Mathews C, Wenham RM, Ramirez PT, Zweizig S, Walker JL.

Am J Obstet Gynecol. 2018 Jan;218(1):109.e1-109.e11. doi: 10.1016/j.ajog.2017.09.026. Epub 2017 Oct 14.

9.

Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.

Kim JS, Mills KA, Fehniger J, Liao C, Hurteau JA, Kirschner CV, Lee NK, Rodriguez GC, Yamada SD, Diaz Moore ES, Tenney ME.

Int J Gynecol Cancer. 2017 Oct;27(8):1774-1782. doi: 10.1097/IGC.0000000000001084.

PMID:
28708786
10.

Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity.

Jimenez-Rivera C, Hadjiyannakis S, Davila J, Hurteau J, Aglipay M, Barrowman N, Adamo KB.

BMC Pediatr. 2017 Apr 26;17(1):113. doi: 10.1186/s12887-017-0867-z.

11.

Omitting lymphadenectomy in patients with endometrial cancer.

Hurteau JA.

Cancer. 2017 Jan 1;123(2):197-199. doi: 10.1002/cncr.30346. Epub 2016 Nov 7. No abstract available.

12.

Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.

Ezewuiro O, Grushko TA, Kocherginsky M, Habis M, Hurteau JA, Mills KA, Hunn J, Olopade OI, Fleming GF, Romero IL.

PLoS One. 2016 Jan 20;11(1):e0147145. doi: 10.1371/journal.pone.0147145. eCollection 2016.

13.

Germ cell tumors: Treatment consensus across all age groups through MaGIC [Malignant Germ Cell International Collaborative].

Hurteau JA, Febbraro T.

Cancer. 2016 Jan 15;122(2):181-3. doi: 10.1002/cncr.29729. Epub 2015 Oct 20. No abstract available.

14.

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, Covens A, Hurteau J, Stenning SP, Feldman DR, Grimison PS, Huddart RA, Sweeney C, Powles T, Lopes LF, dos Santos Agular S, Chinnaswamy G, Khaleel S, Abouelnaga S, Hale JP, Frazier AL.

J Clin Oncol. 2015 Sep 20;33(27):3018-28. doi: 10.1200/JCO.2014.60.5337. Epub 2015 Aug 24. Review. Erratum in: J Clin Oncol. 2015 Nov 20;33(33):3981.

15.

Patterns and utility of routine surveillance in high grade endometrial cancer.

Hunn J, Tenney ME, Tergas AI, Bishop EA, Moore K, Watkin W, Kirschner C, Hurteau J, Rodriguez GC, Lengyel E, Lee NK, Yamada SD.

Gynecol Oncol. 2015 Jun;137(3):485-9. doi: 10.1016/j.ygyno.2015.03.047. Epub 2015 Mar 30.

16.

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.

Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel B, Buss MK, Nattam S, Hurteau J, Luo W, Quy P, Whalen C, Obermayer L, Lee H, Winer EP, Kohn EC, Ivy SP, Matulonis UA.

Lancet Oncol. 2014 Oct;15(11):1207-14. doi: 10.1016/S1470-2045(14)70391-2. Epub 2014 Sep 10.

17.

Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.

Glasspool RM, González Martín A, Millan D, Lorusso D, Åvall-Lundqvist E, Hurteau JA, Davis A, Hilpert F, Kim JW, Alexandre J, Ledermann JA.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S26-9. doi: 10.1097/IGC.0000000000000209. Review.

PMID:
25126954
18.

Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2014 Jul;19(7):689-92. doi: 10.1634/theoncologist.2014-0009. Epub 2014 Jun 4. No abstract available. Erratum in: Oncologist. 2018 Feb;23 (2):272.

19.

Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.

Damania D, Roy HK, Kunte D, Hurteau JA, Subramanian H, Cherkezyan L, Krosnjar N, Shah M, Backman V.

Int J Cancer. 2013 Sep 1;133(5):1143-52. doi: 10.1002/ijc.28122. Epub 2013 Apr 1.

20.

Severe craniosynostosis in an infant with deletion 22q11.2 syndrome.

Al-Hertani W, Hastings VA, McGowan-Jordan J, Hurteau J, Graham GE.

Am J Med Genet A. 2013 Jan;161A(1):153-7. doi: 10.1002/ajmg.a.35491. Epub 2012 Dec 13.

PMID:
23239640
21.

Ovarian cancer : making its own rules-again.

Kohn EC, Hurteau J.

Cancer. 2013 Feb 1;119(3):474-6. doi: 10.1002/cncr.27833. Epub 2012 Dec 11. Review. No abstract available.

22.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.

Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, Rosenquist R, Karlsson P, Nathanson K, Domchek S, Rebbeck T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Złowowcka-Perłowska E, Osorio A, Durán M, Andrés R, Benítez J, Hamann U, Hogervorst FB, van Os TA, Verhoef S, Meijers-Heijboer HE, Wijnen J, Gómez Garcia EB, Ligtenberg MJ, Kriege M, Collée JM, Ausems MG, Oosterwijk JC, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Rogers MT, Donaldson A, Dorkins H, Godwin AK, Bove B, Stoppa-Lyonnet D, Houdayer C, Buecher B, de Pauw A, Mazoyer S, Calender A, Léoné M, Bressac-de Paillerets B, Caron O, Sobol H, Frenay M, Prieur F, Ferrer SU, Mortemousque I, Buys S, Daly M, Miron A, Terry MU, Hopper JL, John EM, Southey M, Goldgar D, Singer CF, Fink-Retter A, Tea MK, Kaulich DU, Hansen TV, Nielsen FC, Barkardottir RB, Gaudet M, Kirchhoff T, Joseph V, Dutra-Clarke A, Offit K, Piedmonte M, Kirk J, Cohn D, Hurteau J, Byron J, Fiorica J, Toland AE, Montagna M, Oliani C, Imyanitov E, Isaacs C, Tihomirova L, Blanco I, Lazaro C, Teulé A, Valle JD, Gayther SA, Odunsi K, Gross J, Karlan BY, Olah E, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EU, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schäfer D, Caldes T, de la Hoya M, Nevanlinna H, Muranen TA, Lespérance B, Spurdle AB, Neuhausen SL, Ding YC, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Loud JT, Andrulis IL, Ozcelik H, Mulligan AU, Glendon G, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Chenevix-Trench G, Couch FJ, Simard J, Easton DF; CIMBA, SWE-BRCA; HEBON; EMBRACE; GEMO Collaborators Study; kConFab Investigators.

Breast Cancer Res. 2012 Feb 20;14(1):R33.

23.

Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.

Rodriguez GC, Turbov JM, Berchuck A, Stack MS, Hurteau JA, Thaete LG, Barry CP.

Am J Obstet Gynecol. 2012 Mar;206(3):253.e1-9. doi: 10.1016/j.ajog.2011.11.012. Epub 2011 Nov 25.

PMID:
22206747
24.

Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.

Shaikh F, Johnston D, Michaud J, Hurteau J, Vassilyadi M, Keene D.

Pediatr Blood Cancer. 2011 Oct;57(4):688-6690. doi: 10.1002/pbc.23143. Epub 2011 Apr 4.

PMID:
21465640
25.

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.

Usha L, Sill MW, Darcy KM, Benbrook DM, Hurteau JA, Michelin DP, Mannel RS, Hanjani P, De Geest K, Godwin AK.

Gynecol Oncol. 2011 Jun 1;121(3):455-61. doi: 10.1016/j.ygyno.2011.02.013. Epub 2011 Mar 17.

26.
27.

Cardiac metastasis from poorly differentiated carcinoma of the cervix: a case report.

Miller ES, Hoekstra AV, Hurteau JA, Rodriguez GC.

J Reprod Med. 2010 Jan-Feb;55(1-2):78-80.

PMID:
20337214
28.

The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.

Weinberg LE, Rodriguez G, Hurteau JA.

J Surg Oncol. 2010 Mar 15;101(4):334-43. doi: 10.1002/jso.21482. Review.

PMID:
20187069
29.

A novel missense mutation in LIS1 in a child with subcortical band heterotopia and pachygyria inherited from his mildly affected mother with somatic mosaicism.

Mineyko A, Doja A, Hurteau J, Dobyns WB, Das S, Boycott KM.

J Child Neurol. 2010 Jun;25(6):738-41. doi: 10.1177/0883073809343312. Epub 2009 Oct 6.

PMID:
19808989
30.

The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.

Hoekstra AV, Hurteau JA, Kirschner CV, Rodriguez GC.

Gynecol Oncol. 2009 Dec;115(3):377-81. doi: 10.1016/j.ygyno.2009.08.021. Epub 2009 Oct 1.

PMID:
19800107
31.

Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer.

Sharma A, Belna J, Espat J, Rodriguez G, Cannon VT, Hurteau JA.

Am J Obstet Gynecol. 2009 May;200(5):516.e1-6. doi: 10.1016/j.ajog.2008.12.023. Epub 2009 Mar 9.

PMID:
19268879
32.

Factors associated with epilepsy in children with periventricular leukomalacia.

Humphreys P, Deonandan R, Whiting S, Barrowman N, Matzinger MA, Briggs V, Hurteau J, Wallace E.

J Child Neurol. 2007 May;22(5):598-605.

PMID:
17690068
33.

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1356-65. Epub 2006 Jun 6.

PMID:
16757127
34.

The effects of Omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines.

Sharma A, Belna J, Logan J, Espat J, Hurteau JA.

Gynecol Oncol. 2005 Oct;99(1):58-64.

PMID:
16043214
35.

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.

Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W Jr, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1078-86.

PMID:
15752887
36.

The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.

Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, Look KY.

Int J Gynecol Cancer. 2004 Jan-Feb;14(1):104-9.

PMID:
14764037
37.

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.

Young RC, Brady MF, Nieberg RK, Long HJ, Mayer AR, Lentz SS, Hurteau J, Alberts DS.

J Clin Oncol. 2003 Dec 1;21(23):4350-5.

PMID:
14645424
38.

Gestational trophoblastic disease: management of hydatidiform mole.

Hurteau JA.

Clin Obstet Gynecol. 2003 Sep;46(3):557-69. Review. No abstract available.

PMID:
12972737
39.

Visualization of the epigastric vessels and bladder before laparoscopic trocar placement.

Hurd WW, Amesse LS, Gruber JS, Horowitz GM, Cha GM, Hurteau JA.

Fertil Steril. 2003 Jul;80(1):209-12.

PMID:
12849826
40.

Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth.

Hurteau JA, Brutkiewicz SA, Wang Q, Allison BM, Goebl MG, Harrington MA.

Gynecol Oncol. 2002 Jul;86(1):19-23.

PMID:
12079294
41.

Effect of carbon dioxide on human ovarian carcinoma cell growth.

Smidt VJ, Singh DM, Hurteau JA, Hurd WW.

Am J Obstet Gynecol. 2001 Dec;185(6):1314-7.

PMID:
11744902
42.

Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.

Hurteau JA, Allison BM, Brutkiewicz SA, Goebl MG, Heilman DK, Bigsby RM, Harrington MA.

Gynecol Oncol. 2001 Nov;83(2):292-8.

PMID:
11606087
43.

Cervical primitive neuroectodermal tumor.

Tsao AS, Roth LM, Sandler A, Hurteau JA.

Gynecol Oncol. 2001 Oct;83(1):138-42.

PMID:
11585426
44.
45.

DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.

Ahluwalia A, Yan P, Hurteau JA, Bigsby RM, Jung SH, Huang TH, Nephew KP.

Gynecol Oncol. 2001 Aug;82(2):261-8.

PMID:
11531277
46.
47.

A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.

Plaxe SC, Blessing JA, Lucci JA, Hurteau JA.

Invest New Drugs. 2001;19(1):77-80.

PMID:
11291835
48.

Location of the ureters in relation to the uterine cervix by computed tomography.

Hurd WW, Chee SS, Gallagher KL, Ohl DA, Hurteau JA.

Am J Obstet Gynecol. 2001 Feb;184(3):336-9.

PMID:
11228483
49.

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.

Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC Jr, Stack MS.

Gynecol Oncol. 2001 Feb;80(2):245-53.

PMID:
11161867
50.

Cardiac electron-beam CT in children undergoing surgical repair for pulmonary atresia.

Westra SJ, Hurteau J, Galindo A, McNitt-Gray MF, Boechat MI, Laks H.

Radiology. 1999 Nov;213(2):502-12.

PMID:
10551233

Supplemental Content

Loading ...
Support Center